Demographic data, treatment modalities, recanalization results, time to recanalization, and NIHSS scores on admission and 1 day after intervention of patients treated with (group A) and without the Solitaire FR Revascularization Device (group B)
| Group A | Group B | P Value | |
|---|---|---|---|
| Age (yr) (median [IQR]) | 66 (61–77) | 68 (57.5–78) | NS |
| Sex (%), female | 41 | 35 | NS |
| NIHSS score, median (IQR) | 19 (14–22) | 12.5 (10–15.5) | .018 |
| Arterial hypertension (%) | 65 | 65 | NS |
| Diabetes mellitus (%) | 18 | 17 | NS |
| Hypercholesterolemia (%) | 71 | 65 | NS |
| Nicotine abuse (%) | 18 | 17 | NS |
| Intravenous thrombolysis (%) | 35 | 22 | NS |
| Multimodal therapy (%) | 76 | 74 | NS |
| Thrombaspiration (%) | 41 | 61 | NS |
| Intra-arterial thrombolysis | 53 | 87 | .017 |
| Urokinase dose (IU), median (IQR) | 250 000 (0–500 000) | 700 000 (475 000–1 000 000) | .006 |
| Stent/PTA (%) | 24 | 35 | NS |
| Intubation (%) | 88 | 70 | NS |
| Recanalization TIMI 2/3 (%) | 94 | 78 | NS |
| Time to recanalization, min (median [IQR]) | 52.5 (37.5–61) | 90 (66–112.5) | 0.001 |
| NIHSS score 1 d, median (IQR) | 14 (6–20) | 10 (6–20) | NS |
| Good outcome (%; mRS 0–2) at 3 mo follow-up | 43 | 52 | NS |